Next report date
Report period
Q1 2024
EPS estimate
−7.60USD
Revenue estimate
—
−76.57USD
−8.95 MUSD
508.79 K
About Bone Biologics Corp
Sector
Industry
CEO
Jeffrey Frelick
Website
Headquarters
Burlington
Employees (FY)
2
Founded
2004
FIGI
BBG007GF2K51
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BBLG is 1.56 USD — it has decreased by 0.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bone Biologics Corp stocks are traded under the ticker BBLG.
Bone Biologics Corp is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
BBLG stock is 5.16% volatile and has beta coefficient of −0.72. Check out the list of the most volatile stocks — is Bone Biologics Corp there?
Yes, you can track Bone Biologics Corp financials in yearly and quarterly reports right on TradingView.
BBLG stock has fallen by 1.17% compared to the previous week, the month change is a 23.46% fall, over the last year Bone Biologics Corp has showed a 97.35% decrease.
BBLG net income for the last quarter is −1.55 M USD, while the quarter before that showed −1.92 M USD of net income which accounts for 19.26% change. Track more Bone Biologics Corp financial stats to get the full picture.
Today Bone Biologics Corp has the market capitalization of 836.08 K, it has decreased by 8.57% over the last week.
No, BBLG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BBLG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bone Biologics Corp stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has 2.00 employees. See our rating of the largest employees — is Bone Biologics Corp on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bone Biologics Corp technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bone Biologics Corp stock shows the sell signal. See more of Bone Biologics Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Bone Biologics Corp future price: according to them, BBLG price has a max estimate of 19.50 USD and a min estimate of 19.50 USD. Read a more detailed Bone Biologics Corp forecast: see what analysts think of Bone Biologics Corp and suggest that you do with its stocks.